Inventiva (IVA) Accounts Payables (2018 - 2025)

Inventiva's (IVA) quarterly Accounts Payables came in at $30.3 million in Q4 2025, down 13.76% year-on-year from $35.1 million in Q4 2024, and down 99.92% quarter-over-quarter from $39.3 billion in Q2 2025.

Inventiva (IVA) Accounts Payables (2018 - 2025) Analysis & Trends

Inventiva's Accounts Payables history runs 8 years deep, the most recent figure standing at $30.3 million for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 13.76% year-over-year to $30.3 million in Q4 2025; TTM through Dec 2025 was $30.3 million, a 13.76% decrease from a year earlier, with the FY2025 full-year figure at $30.3 million, down 13.76% from the prior year.
  • Accounts Payables eased to $30.3 million in Q4 2025 per IVA's latest filing, from $39.3 billion in the prior quarter.
  • Across five years, Accounts Payables topped out at $39.3 billion in Q2 2025 and bottomed at $10.4 million in Q4 2023.
  • The 5-year median for Accounts Payables is $30.8 million (2023), against an average of $4.6 billion.
  • Across the five-year window, Accounts Payables surged 123896.19% in 2022 and sank 99.79% in 2023, its largest moves.
  • Year by year, Accounts Payables stood at $16.7 million in 2021, then rose by 18.24% to $19.8 million in 2022, then soared by 105.26% to $40.5 million in 2023, then fell by 13.38% to $35.1 million in 2024, then slipped by 13.76% to $30.3 million in 2025.
  • Per Business Quant, the three latest IVA Accounts Payables figures stand at $30.3 million (Q4 2025), $39.3 billion (Q2 2025), and $35.1 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Inventiva 842.48 Mn 842.48 Mn - 30.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 30.28 Mn
Jun 30, 2025 39.28 Bn
Dec 31, 2024 35.12 Mn
Jun 30, 2024 40.58 Mn
Dec 31, 2023 40.54 Mn
Oct 11, 2023 10.40 Mn
Jun 30, 2023 31.24 Mn
Dec 31, 2022 19.75 Mn
Jun 30, 2022 15.21 Bn
Dec 31, 2021 16.70 Mn
Jun 30, 2021 12.27 Mn
Mar 31, 2021 10.48 Mn
Dec 31, 2020 8.25 Mn
Jun 30, 2020 9.39 Mn
Dec 31, 2019 8.29 Mn
Dec 31, 2018 9.56 Mn